This inventor holds 1 USPTO granted patent. Top assignee: University of Manitoba. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Puck Bertyne Van Kasteren: Innovator in Arterivirus Research
Introduction
Puck Bertyne Van Kasteren is a notable inventor based in Bussum, Netherlands. She has made significant contributions to the field of virology, particularly in the study of arteriviruses. Her innovative work has led to advancements in medical applications and vaccine development.
Latest Patents
Puck Bertyne Van Kasteren holds a patent for "Live attenuated replication-competent arteriviruses having decreased DUB/deISGylating activity." This invention relates to replication-competent arteriviruses that exhibit a decreased DUB/deISGylating activity due to a mutation in the PLP2 domain of the non-structural protein nsp2. The patent outlines their use as a medicament, their application in vaccines, and their role in prophylaxis, along with the development of Arteriviral PLP2-ubiquitin complexes.
Career Highlights
Puck is affiliated with the University of Manitoba, where she continues her research and development in virology. Her work has garnered attention for its potential impact on vaccine efficacy and disease prevention.
Collaborations
Puck collaborates with esteemed colleagues, including Brian Mark and Eric John Snijder, who contribute to her research endeavors and enhance the scope of her work.
Conclusion
Puck Bertyne Van Kasteren is a pioneering inventor whose research in arterivirus has the potential to revolutionize vaccine development and therapeutic strategies. Her contributions to science are invaluable and continue to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile